News | Peripheral Artery Disease (PAD) | December 29, 2017

Oceanus 14 Pro PTA Balloon Catheter Receives CE Mark Approval

Device approved to dilate stenoses in femoral, popliteal and infrapopliteal arteries

December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (PTA) balloon catheter following CE Mark approval. The device was approved to dilate stenoses in femoral, popliteal and infrapopliteal arteries, and to treat obstructive lesions in arteriovenous dialysis fistulae.

Oceanus 14 Pro features what the company calls an exceptional crossing profile and size range, including ultra-small diameters (1.25mm and 1.5mm) and lengths (10mm and 15mm). It is the only PTA catheter that adapts its number and type of radiopaque markers for enhanced visibility, flexibility and trackability:

  • One tungsten radiopaque marker for the smallest and shortest balloons;
  • Two tungsten radiopaque markers for smaller diameters and lengths over 20mm; and
  • Two metallic radiopaque markers for other references.

For more information: www.ivascular.global


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now